The importance of correction for tissue fraction effects in lung PET: preliminary findings
- 415 Downloads
It has recently been recognized that PET/CT may play a role in diffuse parenchymal lung disease. However, interpretation can be confounded due to the variability in lung density both within and between individuals. To address this issue a novel correction method is proposed.
A CT scan acquired during shallow breathing is registered to a PET study and smoothed so as to match the PET resolution. This is used to derive voxel-based tissue fraction correction factors for the individual. The method was evaluated in a lung phantom study in which the lung was simulated by a Styrofoam/water mixture. The method was further evaluated using 18F-FDG in 12 subjects free from pulmonary disease where ranges before and after correction were considered.
Correction resulted in similar activity concentrations for the lung and background regions, consistent with the experimental phantom set-up. Correction resulted in reduced inter- and intrasubject variability in the estimated SUV. The possible application of the method was further demonstrated in five subjects with interstitial lung changes where increased SUV was demonstrated. Single study pre- and post-treatment studies were also analysed to further illustrate the utility of the method.
The proposed tissue fraction correction method is a promising technique to account for variability of density in interpreting lung PET studies.
KeywordsDiffuse parenchymal lung disease PET/CT 18F-FDG Tissue fraction correction
We acknowledge support for some scan costs and partial salary (T.L.) from GlaxoSmithKline (CRT115549). We also thank Dr. Pauline Lukey and Dr. Aiden Flynn (Fibrosis DPU, GSK) as well as the CRAFT Consortium for useful discussions. Also UCL/UCLH receives a portion of its research funding from the UK Department of Health’s NIHR Biomedical Research Centre funding scheme.
Conflicts of Interest
- 8.Win T, Screaton NJ, Porter JC, Endozo R, Kayani I, Dickson JC, Reubi JC, Ell PJ, Groves AM. Novel PET/CT imaging of diffuse parenchymal lung disease combining a labelled somatostatin receptor analogue and 18F-FDG. Molecular Imaging. 2011 (in press March 2011).Google Scholar
- 11.Miyuachi T, Wahl RL. Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung. Eur J Nucl Med. 1996;23:517–23.Google Scholar
- 13.American Thoracic Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277–304.Google Scholar
- 19.Bovik A. The essential guide to image processing. 2nd ed. New York: Academic Press; 2009.Google Scholar
- 27.Evitzky MG. Pulmonary pathophysiology: a clinical approach. 3rd ed (Kindle edition). New York: McGraw-Hill Medical; 2009.Google Scholar